Latest News & Updates of Loncom Pharma

Abemaciclib, developed by Eli Lilly, represents a significant advancement in the treatment of advanced or metastatic breast cancer. Its approval in September 2017 by the US FDA marked a new chapter for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HE

Levosimendan, known chemically as a hydrazone, pyridazinone, and nitrile, has emerged as a critical drug in cardiac care. Initially developed in the late 1990s, Levosimendan has carved out a niche in managing acute cardiac conditions that necessitate immediate and potent intervention.

In recent years, a new medication called Elagolix Sodium has emerged as a promising treatment for women suffering from endometriosis and uterine fibroids, offering significant relief from these debilitating conditions.Understanding Elagolix SodiumElagolix sodium is an oral medication that works as a

Niraparib Tosylate-A Promising Treatment for Ovarian CancerOvarian cancer is a devastating disease that affects thousands of women worldwide. Despite advancements in medical research, the prognosis for patients with advanced ovarian cancer remains poor. However, there is new hope on the horizon with